Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications

Journal of Bone and Mineral Research

Volumn 24, Issue 4, 2009, Pages 702-709

  Yamamoto, Masahiro ^a   Yamaguchi, Toru ^a   Yamauchi, Mika ^a   Kaji, Hiroshi ^b   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BMD; Osteoporosis; Type 2 diabetes; Vertebral fracture

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; BONE DENSITY; BONE FRAGILITY; BONE STRENGTH; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PREVALENCE; QUALITATIVE ANALYSIS; RADIUS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; BONE DENSITY; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SPINAL FRACTURES;

EID: 65549127209     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081207     Document Type: Article

References (42)

1. Janghorbani M, Van Dam RM, Willett WC, Hu FB 2007 Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495-505.
2. Vestergaard P, Rejnmark L, Mosekilde L 2005 Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292-1299.
3. Hanley DA. Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C. Joseph L, Papaioannou A. Jackson SA, Poliquin S, Adachi JD 2003 Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: Cross- sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18:784-790.
4. Gerdhem P. Tsaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512.
5. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA 1999 Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 353:878-882.
6. Vestergaard P 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18:427-444.
7. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T 2007 Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif Tissue Int 80:353-358.
8. Orwoll ES, Oviatt SK, Mann T 1990 The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 70:1202-1207.
9. Liu G, Peacock M, Eilam O, Dorulla G, Braunstein E, Johnston CC 1997 Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 7:564-569.
10. Orimo H, Sugioka Y, Fukunaga M. Mutou Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Inokai T 1996 Diagnostic criteria for primary osteoporosis in Japan. Osteoporosis Jpn 4:643-653.
11. Genant HK, Wu CY, van Kuijk C, Nevitt MC 1993 Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148.
12. Hanley JA, McNeil BJ 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36.
13. Patel S, Hyer S, Tweed K, Kerry S, Allan K, Rodin A, Barron J 2008 Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int 82:87-91.
14. Ivers RQ, dimming RG, Mitchell P. Peduto AJ 2001 Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24:1198-1203.
15. Saito M, Fujii K, Mori Y. Marumo K 2006 Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17:1514-1523.
16. Yamamoto M. Yamaguchi T, Yamauchi M, Yano S. Sugimoto T 2008 Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 93:1013-1019.
17. Dominguez LJ, Barbagallo M, Moro L 2005 Collagen over-glycosylation: A biochemical feature that may contribute to bone quality. Biochem Biophys Res Commun 330:1-4.
18. McNair P, Madsbad S, Christensen MS. Christiansen C, Faber OK, Binder C, Transbol I 1979 Bone mineral loss in insulin-treated diabetes mellitus: Studies on pathogenesis. Acta Endocrinol (Copenh) 90:463-472.
19. McNair P, Christensen MS, Madsbad S, Christiansen C, Transbol I 1981 Hypoparathyroidism in diabetes mellitus. Acta Endocrinol (Copenh) 96:81-86.
20. Shimoaka T, Kamekura S, Chikuda H. Hoshi K. Chung UI, Akune T, Maruyama Z, Komori T. Matsumoto M, Ogawa W, Terauchi Y, Kadowaki T, Nakamura K, Kawaguchi H 2004 Impairment of bone healing by insulin receptor substrate-1 deficiency. J Biol Chem 279:15314-15322.
21. Akune T, Ogata N. Hoshi K, Kubota N. Terauchi Y, Tobe K. Takagi H, Azuma Y. Kadowaki T. Nakamura K. Kawaguchi H 2002 Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 159:147-156.
22. McCarthy TL, Centrella M, Canalis E 1989 Insulin-like growth factor (IGF) and bone. Connect Tissue Res 20:277-282.
23. Daughaday WH, Phillips LS, Mueller MC 1976 The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214-1219.
24. Scott CD, Baxter RC 1986 Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology 119:2346-2352.
25. Jehle PM, Jehle DR, Mohan S. Bohm BO 1998 Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol 159:297-306.
26. Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T 2006 Serum levels of insulin-like growth factor (IGF); IGF-binding proteins- 3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78:18-24.
27. Szule P, Joly-Pharaboz MO, Marchand F, Delmas PD 2004 Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age; MINOS study. Calcif Tissue Int 74:322-329.
28. Krassas GE, Papadopoulou P. Koliakos G. Konstantinidis T, Kalothetou K 2003 Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men. Arch Androl 49:191-199.
29. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG 2002 Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70:22-29.
30. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T 2007 Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 18:1675-1681.
31. Baillie SP, Davison CE, Johnson FJ, Francis RM 1992 Pathogenesis of vertebral crush fractures in men. Age Ageing 21:139-141.
32. Seeman E, Melton LJ III, O'Fallon WM, Riggs BL 1983 Risk factors for spinal osteoporosis in men. Am J Med 75:977-983.
33. Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ, Chappie CL 1999 Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 9:91-97.
34. Tan RS, Pu SJ 2002 Impact of obesity on hypogonadism in the andropause. Int J Androl 25:195-201.
35. Barrett-Connor E, Khaw KT, Yen SS 1990 Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132:895-901.
36. Holmberg AH. Johnell O, Nilsson PM, Nilsson J, Berglund G. Akesson K 2006 Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:1065-1077.
37. Lipscombe LL, Jamal SA, Booth GL, Hawker GA 2007 The risk of hip fractures in older individuals with diabetes: A population-based study. Diabetes Care 30:835-841.
38. Schwartz AV, Sellmeyer DE. Vittinghoff E. Palermo L, Lecka-Czernik B, Feingold KR. Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB. Cummings SR 2006 Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91:3349-3354.
39. Yaturu S, Bryant B. Jain SK 2007 Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care 30:1574-1576.
40. Dawson-Hughes B, Harris SS, Krall EA, Dallai GE 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
41. Mezquita-Raya P, Munoz-Tones M, Luna JD, Luna V, Lopez-Rodriguez F, Torres-Vela E, Escobar-Jimenez F 2001 Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res 16:1408-1415.
42. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N. Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G 2002 Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560-569.